Analysing horizontal equity in enrolment in Disease Management Programmes for coronary heart disease in Germany 2008–2010

International Journal for Equity in Health

Joachim Szecsenyi¹  Antje Miksch¹  Bernd Holleczek²  Kai-Uwe Saum³  Werner Maier⁶  Oliver Razum⁵  Hermann Brenner³  Miguel San Sebastian⁴  Kayvan Bozorgmehr¹ 

[1] Department of General Practice & Health Services Research, University Hospital Heidelberg, Heidelberg, Germany;Saarland Cancer Registry, Saarbrücken, Germany;Division of Clinical Epidemiology and Aging Research, German Cancer Research Center (DKFZ), Heidelberg, Germany;Division of Epidemiology and Global Health, Department of Public Health and Clinical Medicine, Umeå University, Umeå, Sweden;Department of Epidemiology & International Public Health, School of Public Health, Bielefeld University, Bielefeld, Germany;Institute of Health Economics and Health Care Management, Helmholtz Zentrum München - German Research Center for Environmental Health (GmbH), Neuherberg, Germany

关键词: Coronary heart disease;    Regional deprivation;    Concentration index;    Horizontal inequity index;    Health services;    Equity;   

Others  :  1139290
DOI  :  10.1186/s12939-015-0155-1

 received in 2014-07-11, accepted in 2015-02-24,  发布年份 2015

【 摘 要 】

Background

Disease Management Programmes (DMPs) have been introduced in Germany ten years ago with the aim to improve effectiveness and equity of care, but little is known about the degree to which enrolment in the programme meets the principles of equity in health care. We aimed to analyse horizontal equity in DMP enrolment among patients with coronary heart disease (CHD).

Methods

Cross-sectional analysis of horizontal inequities in physician-reported enrolment in the DMP for CHD in a large population-based cohort-study in Germany (2008–2010). We calculated horizontal inequity indices (HII) and their 95% confidence intervals [95%CI] for predicted need-standardised DMP enrolment across two measures of socio-economic status (SES) (educational attainment, regional deprivation) stratified by sex. Need-standardised DMP enrolment was predicted in multi-level logistic regression models.

Results

Among N = 1,280 individuals aged 55–84 years and diagnosed with CHD, DMP enrolment rates were 22.2% (women) and 35.0% (men). Education-related inequities in need-standardised DMP enrolment favoured groups with lower education, but HII estimates were not significant. Deprivation-related inequities among women significantly favoured groups with higher SES (HII = 0.086 [0.007 ; 0.165]. No such deprivation-related inequities were seen among men (HII = 0.014 [−0.048 ; 0.077]). Deprivation-related inequities across the whole population favoured groups with higher SES (HII estimates not significant).

Conclusion

Need-standardised DMP enrolment was fairly equitable across educational levels. Deprivation-related inequities in DMP enrolment favoured women living in less deprived areas relative to those living in areas with higher deprivation. Further research is needed to gain a better understanding of the mechanisms that contribute to deprivation-related horizontal inequities in DMP enrolment among women.

【 授权许可】

   
2015 Bozorgmehr et al.; licensee BioMed Central.

【 图 表 】

Figure 1.

Figure 2.

Figure 3.

Figure 4.

Figure 5.

【 参考文献 】

• [1]Murray CJ, Vos T, Lozano R, Naghavi M, Flaxman AD, Michaud C, et al.: Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 2012, 380:2197-223.
• [2]Lozano R, Naghavi M, Foreman K, Lim S, Shibuya K, Aboyans V, et al.: Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 2012, 380:2095-128.
• [3]Federal Statistical Office (Destatis). [Todesursachen in Deutschland]. www.destatis.de Fachserie 12, Reihe 4. 2014. Wiesbaden, Statistisches Bundesamt. Gesundheit. 4/1/14.
• [4]Joint Federal Commission (G-BA): [Zwanzigste Verordnung zur Änderung der Risikostruktur-Ausgleichsverordnung (20.RSA-ÄndV) Vom 23. Juni 2009] Bundesgesetzblatt 2009, I:1551-61.
• [5]Szecsenyi J, Rosemann T, Joos S, Peters-Klimm F, Miksch A: German diabetes disease management programs are appropriate for restructuring care according to the chronic care model: an evaluation with the patient assessment of chronic illness care instrument. Diabetes Care 2008, 31:1150-4.
• [6]Busse R: Disease Management Programs In Germanys Statutory Health Insurance System. Health Affair 2004, 23:56-67.
• [7]Pilnick A, Dingwall R, Starkey K: Disease management: definitions, difficulties and future directions. Bull World Health Organ 2001, 79:755-63.
• [8]German Federal (Social) Insurance Office (BVA). [Zulassung der Disease Management Programme (DMP) durch das Bundesversicherungsamt (BVA)]. http://www.bundesversicherungsamt.de. 2014. 4/1/14.
• [9]Gapp O, Schweikert B, Meisinger C, Holle R: Disease management programmes for patients with coronary heart disease–an empirical study of German programmes. Health Policy 2008, 88:176-85.
• [10]Stark R, Kirchberger I, Hunger M, Heier M, Leidl R, Scheidt W, et al.: Improving care of post-infarct patients: effects of disease management programmes and care according to international guidelines. Clin Res Cardiol 2014, 103:237-45.
• [11]Drabik A, Sawicki PT, Muller D, Passon A, Stock S: The methods within the evaluation of disease management programmes in control-group designs using the example of diabetes mellitus - a systematic literature review. Gesundheitswesen 2012, 74:496-501.
• [12]Miksch A, Laux G, Ose D, Joos S, Campbell S, Riens B, et al.: Is there a survival benefit within a German primary care-based disease management program? Am J Manag Care 2010, 16:49-54.
• [13]Schäfer I, Küver C, Gedrose B, von Leitner EC, Treszl A, Wegscheider K, et al.: Selection effects may account for better outcomes of the German Disease Management Program for type 2 diabetes. BMC Health Serv Res 2010, 10:351. BioMed Central Full Text
• [14]Greß S, Focke A, Hessel F, Wasem J: Financial incentives for disease management programmes and integrated care in German social health insurance. Health Policy 2006, 78:295-305.
• [15]Tugwell P, De SD, Hawker G, Robinson V: Applying clinical epidemiological methods to health equity: the equity effectiveness loop. BMJ 2006, 332:358-61.
• [16]Starfield B: Improving equity in health: a research agenda. Int J Health Serv 2001, 31:545-66.
• [17]Raum E, Rothenbacher D, Low M, Stegmaier C, Ziegler H, Brenner H: Changes of cardiovascular risk factors and their implications in subsequent birth cohorts of older adults in Germany: a life course approach. Eur J Cardiovasc Prev Rehabil 2007, 14:809-14.
• [18]Schöttker B, Haug U, Schomburg L, Köhrle J, Perna L, Müller H, et al. Strong associations of 25-hydroxyvitamin D concentrations with all-cause, cardiovascular, cancer, and respiratory disease mortality in a large cohort study. Am J Clin Nutr. 2013;97(4):782-93.
• [19]Schöttker B, Herder C, Rothenbacher D, Roden M, Kolb H, Müller H, et al.: Proinflammatory cytokines, adiponectin, and increased risk of primary cardiovascular events in diabetic patients with or without renal dysfunction: results from the ESTHER study. Diabetes Care 2013, 36:1703-11.
• [20]Wagstaff A, Doorslaer E: Measuring and testing for inequity in the delivery of health care. J Hum Resour 2000, 35:716-33.
• [21]O'Donnell O, van Doorslaer E, Wagstaff A, Lindelow M: Measuring and Explaining Inequity in Health Service Delivery. [http:/ / siteresources.worldbank.org/ INTPAH/ Resources/ Publications/ 459843-1195594469249/ HealthEquityFINAL.pdf] webciteAnalyzing Health Equity Using Household Survey Data: A Guide to Techniques and their Implementation World Bank, Washington D.C.; 2008, 177-85. http://siteresources.worldbank.org/INTPAH/Resources/Publications/459843-1195594469249/HealthEquityFINAL.pdf (Accessed: 27/02/2015)
• [22]van Doorslaer E, Wagstaff A, van der Burg H, Christiansen T, De Graeve D, Duchesne I, et al.: Equity in the delivery of health care in Europe and the US. J Health Econ 2000, 19:553-83.
• [23]Miller MD, Paradis CF, Houck PR, Mazumdar S, Stack JA, Rifai AH, et al.: Rating chronic medical illness burden in geropsychiatric practice and research: application of the cumulative illness rating scale. Psychiat Res 1992, 41:237-48.
• [24]Maier W, Holle R, Hunger M, Peters A, Meisinger C, Greiser KH, et al.: for the DIAB-CORE Consortium: The impact of regional deprivation and individual socio-economic status on the prevalence of Type 2 diabetes in Germany. A pooled analysis of five population-based studies. Diabet Med 2013, 30:e78-86.
• [25]Maier W, Fairburn J, Mielck A: Regional deprivation and mortality in Bavaria. Development of a community-based index of multiple deprivation. Gesundheitswesen 2012, 74:416-25.
• [26]Abdelkrim A, Duclos J-Y. DASP: Distributive Analysis Stata Package. 2007. PEP; World Bank; UNDP; Université Laval. http://dasp.ecn.ulaval.ca/index.html (Accessed: 27/02/2015).
• [27]Aday LA, Andersen R: Equity of access to medical care: a conceptual and empirical overview. Med Care 1981, 19:4-27.
• [28]Elkeles T, Kirschner W, Graf C, Kellermann-Muehlhoff P: Health care in and outside a DMP for type 2 diabetes mellitus in Germany-results of an insurance customer survey focussing on differences in general education status. J Public Health 2009, 17:205-16.
• [29]Miksch A, Trieschmann J, Ose D, Rölz A, Heiderhoff M, Szecsenyi J: General practitioners’ opinion and attitude towards DMPs and the change in practice routines to implement the DMP “Diabetes mellitus Type 2”. Z Evid Fortbild Qual Gesundhwes 2011, 105:427-33.
• [30]Bestehorn K, Jannowitz C, Karmann B, Pittrow D, Kirch W: Characteristics, management and attainment of lipid target levels in diabetic and cardiac patients enrolled in Disease Management Program versus those in routine care: LUTZ registry. BMC Public Health 2009, 9:280. BioMed Central Full Text
• [31]Galobardes B, Shaw M, Lawlor DA, Lynch JW, Davey SG: Indicators of socioeconomic position (part 1). J Epidemiol Community Health 2006, 60:7-12.
• [32]Regidor E: Measures of health inequalities: part 1. J Epidemiol Community Health 2004, 58:858-61.
• [33]Blümel M, Busse R. Disease Management Programs - Time to evaluate. Health Policy Monitor 2009. Available at: http://www.hpm.org/de/Surveys/TU_Berlin_-_D/13/Disease_Management_Programs___8211__Time_to_evaluate.html (Accessed 27/02/2015).
• [34]Wagstaff A: The concentration index of a binary outcome revisited. Health Econ 2011, 20:1155-60.
• [35]Erreygers G, Van OT: Putting the cart before the horse. A comment on Wagstaff on inequality measurement in the presence of binary variables. Health Econ 2011, 20:1161-5.
• [36]Wagstaff A: Reply to Guido Erreygers and Tom Van Ourti‘s comment on ’The concentration index of a binary outcome revisited’. Health Econ 2011, 20:1166-8.
• [37]O'Donnell O, van Doorslaer E, Wagstaff A, Lindelow M: The Concentration Index. In Analyzing Health Equity Using Household Survey Data: A Guide to Techniques and their Implementation. World Bank, Washington D.C.; 2008:95-108.
• [38]Erreygers G, Van OT: Measuring socioeconomic inequality in health, health care and health financing by means of rank-dependent indices: a recipe for good practice. J Health Econ 2011, 30:685-94.
• [39]Hosseinpoor AR, van Doorslaer E, Speybroek N, Naghavi M, Mohammad K, Majdzadeh R, et al.: Decomposing socio-economic inequality in infant mortality in Iran. Int J Epidemiol 2006, 35:1211-9.
• [40]Erreygers G: Correcting the concentration index. J Health Econ 2009, 28:504-15.
• [41]Wagstaff A: The bounds of the concentration index when the variable of interest is binary, with an application to immunization inequality. Health Econ 2005, 14:429-32.
• [42]Noble M, Wright G, Smith G, Dibben C: Measuring multiple deprivation at the small-area level. Environ Plann A 2006, 38:169-85.
• [43]O’Donnell O: Measuring health inequalities in Europe: Methodological issues in the analysis of survey data. Eurohealth 2009, 15:10-4.
• [44]O'Donnell O, van Doorslaer E, Wagstaff A, Lindelow M: Data for Health Equity Analysis: Requirements, Sources and Sample Design. In Analyzing Health Equity Using Household Survey Data: A Guide to Techniques and their Implementation. World Bank, Washington D.C.; 2008:13-27.
• [45]Wagstaff A, Watanabe N: What difference does the choice of SES make in health inequality measurement? Health Econ 2003, 12:885-90.
• [46]Monteiro CA, Benicio MH, Conde WL, Konno S, Lovadino AL, Barros AJ, et al.: Narrowing socioeconomic inequality in child stunting: the Brazilian experience, 1974–2007. Bull World Health Organ 2010, 88:305-11.